Moderna stock climbs as HSBC upgrades to Buy on underestimated pipeline potential
Shares in biotech firm Moderna (NASDAQ:MRNA) rose more than 4% Monday after HSBC raised its rating on the stock from Hold to ...
Moderna price target lowered to $69 from $115 at Piper Sandler
Piper Sandler lowered the firm’s price target on Moderna (MRNA) to $69 from $115 and keeps an Overweight rating on the shares. The firm notes ...
Moderna upgraded to Hold from Reduce at HSBC
HSBC upgraded Moderna (MRNA) to Hold from Reduce with a $58 price target Don't Miss our Black Friday Offers:Discover the latest stocks ...
The Inter-Mountain9h
Don’t wait for a holiday surge. Now is a good time to get your flu and COVID-19 vaccines
If you missed the early fall push for flu and COVID-19 vaccines, it’s not too late. Health officials say it’s important to get vaccinated ahead of the holidays, when respiratory bugs tend to spread ...
The latest COVID booster will soon be available. Should I get one? Am I eligible?
For young, healthy people who may be wondering, “do I need a COVID booster at all?”, having one annually is sensible.
Vermont Business Magazine6d
VDH: COVID cases up, but serious cases remain low
The number of COVID cases increased last week to 146. Cases had been falling in April and May and were as low as 31 at the ...
The major COVID variants we've seen so far and which one to look out for right now
Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...